Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial.
Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial.
复制标题
DOI:
10.2337/dc12-1079
复制
发表时间:
2013-02
期刊:
影响因子:
16.2
通讯作者:
Steil GM
中科院分区:
文献类型:
--
作者:
Dauber A;Corcia L;Safer J;Agus MS;Einis S;Steil GM
To assess the possibility of improving nocturnal glycemic control as well as meal glycemic response using closed-loop therapy in children aged <7 years. This was a randomized controlled crossover trial comparing closed-loop with standard open-loop insulin pump therapy performed in an inpatient clinical research center. Ten subjects aged <7 years with type 1 diabetes for >6 months treated with insulin pump therapy were studied. Closed-loop therapy and standard open-loop therapy were compared from 10:00 p.m. to 12:00 p.m. on 2 consecutive days. The primary outcome was plasma glucose time in range (110–200 mg/dL) during the night (10:00 p.m.–8:00 a.m.). Secondary outcomes included peak postprandial glucose levels, incidence of hypoglycemia, degree of hyperglycemia, and prelunch glucose levels. A trend toward a higher mean nocturnal time within target range was noted for closed- versus open-loop therapy, although not reaching statistical significance (5.3 vs. 3.2 h, P = 0.12). There was no difference in peak postprandial glucose or number of episodes of hypoglycemia. There was significant improvement in time spent >300 mg/dL overnight with closed-loop therapy (0.18 vs. 1.3 h, P = 0.035) and the total area under the curve of glucose >200 mg/dL (P = 0.049). Closed-loop therapy returned prelunch blood glucose closer to target (189 vs. 273 mg/dL on open loop, P = 0.009). Closed-loop insulin delivery decreases the severity of overnight hyperglycemia without increasing the incidence of hypoglycemia. The therapy is better able to reestablish target glucose levels in advance of a subsequent meal. Younger children with type 1 diabetes may reap significant benefits from closed-loop therapy.
登录
查看更多内容
影响因子:
16.2
作者:
Castle JR;Engle JM;El Youssef J;Massoud RG;Yuen KC;Kagan R;Ward WK
通讯作者:
Ward WK
影响因子:
5.4
作者:
Gandrud, Laura M.;Xing, Dongyuan;Buckingham, Bruce A.
通讯作者:
Buckingham, Bruce A.
影响因子:
16.2
作者:
Swan, Karena L.;Dziura, James D.;Weinzimer, Stuart A.
通讯作者:
Weinzimer, Stuart A.
影响因子:
7.7
作者:
Steil, Garry M.;Rebrin, Kerstin;Saad, Mohammed F.
通讯作者:
Saad, Mohammed F.
影响因子:
16.2
作者:
Weinzimer, Stuart A.;Steil, Garry M.;Tamborlane, Williani V.
通讯作者:
Tamborlane, Williani V.